206 related articles for article (PubMed ID: 30704436)
1. Opioid response in paediatric cancer patients and the Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene: an Italian study on 87 cancer children and a systematic review.
Lucenteforte E; Vannacci A; Crescioli G; Lombardi N; Vagnoli L; Giunti L; Cetica V; Coniglio ML; Pugi A; Bonaiuti R; Aricò M; Giglio S; Messeri A; Barale R; Giovannelli L; Mugelli A; Maggini V
BMC Cancer; 2019 Jan; 19(1):113. PubMed ID: 30704436
[TBL] [Abstract][Full Text] [Related]
2. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
[TBL] [Abstract][Full Text] [Related]
3. An opposite-direction modulation of the COMT Val158Met polymorphism on the clinical response to intrathecal morphine and triptans.
Cargnin S; Magnani F; Viana M; Tassorelli C; Mittino D; Cantello R; Sances G; Nappi G; Canonico PL; Genazzani AA; Raffaeli W; Terrazzino S
J Pain; 2013 Oct; 14(10):1097-106. PubMed ID: 23773341
[TBL] [Abstract][Full Text] [Related]
4. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
[TBL] [Abstract][Full Text] [Related]
5. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
6. Effect of catechol-O-methyltransferase (rs4680) single-nucleotide polymorphism on opioid-induced hyperalgesia in adults with chronic pain.
Hooten WM; Hu D; Cunningham JM; Black JL
Mol Pain; 2019; 15():1744806919848929. PubMed ID: 31041874
[TBL] [Abstract][Full Text] [Related]
7. Catechol-o-methyltransferase polymorphisms predict opioid consumption in postoperative pain.
Candiotti KA; Yang Z; Buric D; Arheart K; Zhang Y; Rodriguez Y; Gitlin MC; Carvalho E; Jaraba I; Wang L
Anesth Analg; 2014 Nov; 119(5):1194-200. PubMed ID: 25185591
[TBL] [Abstract][Full Text] [Related]
8. Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning.
Olesen AE; Grønlund D; Gram M; Skorpen F; Drewes AM; Klepstad P
BMC Res Notes; 2018 Jan; 11(1):78. PubMed ID: 29374492
[TBL] [Abstract][Full Text] [Related]
9. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
10. Associations of catechol-O-methyltransferase (rs4680) single nucleotide polymorphisms with opioid use and dose among adults with chronic pain.
Hooten WM; Biernacka JM; O'Brien TG; Cunningham JM; Black JL
Pain; 2019 Jan; 160(1):263-268. PubMed ID: 30211780
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.
Rakvåg TT; Ross JR; Sato H; Skorpen F; Kaasa S; Klepstad P
Mol Pain; 2008 Dec; 4():64. PubMed ID: 19094200
[TBL] [Abstract][Full Text] [Related]
12. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
Rakvåg TT; Klepstad P; Baar C; Kvam TM; Dale O; Kaasa S; Krokan HE; Skorpen F
Pain; 2005 Jul; 116(1-2):73-8. PubMed ID: 15927391
[TBL] [Abstract][Full Text] [Related]
13. Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal Intubation.
Elens L; Norman E; Matic M; Rane A; Fellman V; van Schaik RH
Ther Drug Monit; 2016 Aug; 38(4):525-33. PubMed ID: 27027462
[TBL] [Abstract][Full Text] [Related]
14. Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain.
De Gregori M; Garbin G; De Gregori S; Minella CE; Bugada D; Lisa A; Govoni S; Regazzi M; Allegri M; Ranzani GN
Eur J Clin Pharmacol; 2013 Sep; 69(9):1651-8. PubMed ID: 23686330
[TBL] [Abstract][Full Text] [Related]
15. Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Sakai K; Yoshida T; Nakura M; Sakamoto R; Makimura C; Ohtake Y; Tanaka K; Hayashi H; Takeda M; Okuno T; Takegawa N; Haratani K; Koyama A; Nishio K; Nakagawa K
Oncologist; 2023 Mar; 28(3):278-e166. PubMed ID: 36426809
[TBL] [Abstract][Full Text] [Related]
16. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
17. The Val158Met polymorphism of the COMT gene is associated with increased pain sensitivity in morphine-treated patients undergoing a painful procedure after cardiac surgery.
Ahlers SJ; Elens LL; van Gulik L; van Schaik RH; van Dongen EP; Bruins P; Tibboel D; Knibbe CA
Br J Clin Pharmacol; 2013 Jun; 75(6):1506-15. PubMed ID: 23210659
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study.
Lucenteforte E; Vagnoli L; Pugi A; Crescioli G; Lombardi N; Bonaiuti R; Aricò M; Giglio S; Messeri A; Mugelli A; Vannacci A; Maggini V
BMC Cancer; 2018 May; 18(1):568. PubMed ID: 29776346
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase gene polymorphism and chronic human pain: a systematic review and meta-analysis.
Tammimäki A; Männistö PT
Pharmacogenet Genomics; 2012 Sep; 22(9):673-91. PubMed ID: 22722321
[TBL] [Abstract][Full Text] [Related]
20. Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients.
Matsuoka H; Arao T; Makimura C; Takeda M; Kiyota H; Tsurutani J; Fujita Y; Matsumoto K; Kimura H; Otsuka M; Koyama A; Imamura CK; Tanigawara Y; Yamanaka T; Tanaka K; Nishio K; Nakagawa K
Oncol Rep; 2012 May; 27(5):1393-9. PubMed ID: 22293824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
